Trina Krug on MSN3d
The Ominous Octet – 8 Hidden Drivers of Type 2 Diabetes
Many individuals are told that managing type 2 diabetes is simply a matter of controlling blood sugar. As long as glucos ...
Medscape7d
The Glucagonostatic and Insulinotropic Effects of Glucagon-like Peptide 1 Contribute Equally to its Glucose-lowering Action
Previous studies have focused on the improvements in β-cell function ... 1 was infused to stimulate endogenous insulin release and suppress endogenous glucagon. On days 2–5, pancreatic ...
News Medical on MSN11d
The emerging role of flavonoids in the treatment of type 2 diabetes mellitus: regulating the enteroendocrine system
Type 2 diabetes mellitus (T2DM) is a prevalent yet complex metabolic disorder that has shown a rising incidence over the past few decades. Recent research has identified flavonoids as compounds ...
News-Medical.Net on MSN5d
Flavonoids help regulate gut hormones and show promise in managing type 2 diabetes
Flavonoids show promise in treating type 2 diabetes mellitus by targeting the enteroendocrine system and regulating key gut ...
Will Using Semaglutide Increase Your Risk of Thyroid Cancer?
New research indicates GLP1-RA medications do not increase thyroid cancer risk, reassuring users and clinicians. A new study, ...
Medscape10d
Can Weight Loss Lead to Real Remission for Type 2 Diabetes?
Despite weight loss and glycemic control, experts caution that type 2 diabetes remission is not a cure and that pancreatic ...
WFTV6d
Is Ozempic a game-changer for insulin resistance? What you need to know
Insulin resistance occurs when the body's cells become less responsive to insulin ... and an increased risk of type 2 diabetes. Ozempic is a glucagon-like peptide-1 (GLP-1) receptor agonist.